Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-17 Purchase |
2025-02-14 4:08 pm |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
35,050 | $0.54927 | $19,252 | 729,173 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 6:15 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
76,473 | $0.454 | $34,719 | 1,087,386 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 6:15 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
74,773 | $0.454 | $33,947 | 0 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 6:15 pm |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
29,159 | $0.4541 | $13,241 | 94,123 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 6:15 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
22,258 | $0.4535 | $10,094 | 490,980 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 6:15 pm |
X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer |
11,624 | $0.4546 | $5,284 | 14,207 (Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 4:31 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
31,897 | $0.3945 | $12,583 | 993,919 (Direct) |
View |
| 2024-10-15 Sale |
2024-10-16 4:54 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
31,897 | $0.562 | $17,926 | 1,025,816 (Direct) |
View |
| 2024-10-07 Sale |
2024-10-08 4:44 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
230,645 | $0.5502 | $126,901 | 0 (Direct) |
View |
| 2024-10-07 Sale |
2024-10-08 4:44 pm |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
11,127 | $0.5847 | $6,506 | 48,509 (Direct) |
View |
| 2024-10-07 Sale |
2024-10-08 4:44 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
239,436 | $0.5493 | $131,522 | 1,057,713 (Direct) |
View |
| 2024-10-07 Sale |
2024-10-08 4:44 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
67,695 | $0.5662 | $38,329 | 452,060 (Direct) |
View |
| 2024-10-07 Sale |
2024-10-08 4:44 pm |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
76,920 | $0.563 | $43,306 | 388,026 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-11 4:01 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
2,642 | $0.6577 | $1,738 | 289,110 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-11 5:20 pm |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
14,235 | $0.8818 | $12,552 | 234,301 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-11 5:20 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
49,678 | $0.8828 | $43,856 | 765,068 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-11 5:19 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
52,500 | $0.8828 | $46,347 | 0 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-11 5:19 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
15,409 | $0.882 | $13,591 | 291,752 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 5:23 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
3,683 | $1.007 | $3,709 | 307,161 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 5:23 pm |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
787 | $1.0072 | $793 | 248,536 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 5:05 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
21,695 | $1.0091 | $21,892 | 814,746 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-12 Option Award |
2025-02-14 4:09 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer |
850,000 | $0 | 864,207 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
850,000 | $0 | 850,000 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
2,250,000 | $0 | 3,337,386 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
600,000 | $0 | 729,173 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
650,000 | $0 | 1,140,980 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 6:15 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
169,940 | $0 | 1,087,386 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 6:15 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
74,773 | $0 | 0 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 6:15 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
74,773 | $0 | 94,123 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 6:15 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
61,178 | $0 | 490,980 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 6:15 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer |
25,831 | $0 | 14,207 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 4:44 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
230,645 | $0 | 0 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 4:44 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
34,946 | $0 | 48,509 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 4:44 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
532,081 | $0 | 1,057,713 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 4:44 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
230,645 | $0 | 452,060 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 4:44 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
230,645 | $0 | 388,026 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 4:13 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | de Craecker Francoise Director |
45,000 | $0 | 96,667 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 4:13 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Aliski William Director |
45,000 | $0 | 96,667 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 4:13 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | MCGIRR DAVID W J Director |
45,000 | $0 | 96,667 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 4:13 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Stewart Murray Director |
45,000 | $0 | 191,504 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 4:12 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Bridger Gary Director |
45,000 | $0 | 96,667 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 4:12 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Woods Keith Director |
45,000 | $0 | 135,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 4:12 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Lawton Alison Frances Director |
45,000 | $0 | 96,667 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 4:12 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | WYZGA MICHAEL S Director |
45,000 | $0 | 121,667 (Direct) |
View |
| 2024-02-13 Option Award(A) |
2024-02-28 5:52 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer |
180,816 | $0 | 180,816 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:11 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer |
475,831 | $0 | 475,831 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:10 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
523,414 | $0 | 523,414 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:09 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
428,248 | $0 | 428,248 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:09 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
1,189,578 | $0 | 1,189,578 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:09 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
523,414 | $0 | 523,414 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:08 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
428,248 | $0 | 428,248 (Direct) |
View |